Article information
Full text is only aviable in PDF
Bibliografía
[1.]
K. Styblo.
Epidemiology of tuberculosis.
Selected papers, Gustav Fischer Verlag Jena, (1991),
[2.]
OMS. 44.a Asamblea Mundial de la Salud. 1991.
[3.]
R.L. Colebunders, et al.
HIV infection in patients with tuberculosis in Kinshasa.
Zaire. Am Rev Respir Dis, 139 (1989), pp. 1.082
[5.]
CDC.
Tuberculosis and acquired immunodeficiency syndrome.
Florida. MMWR, 35 (1986), pp. 587
[6.]
CDC.
Tuberculosis and acquired immunodeficiency syndrome in New York City.
MMWR, 36 (1987), pp. 785
[7.]
C.P. Theuer, et al.
Human immunodeficiency virus infection in tuberculosis patients.
J Infect Dis, 162 (1990), pp. 8
[8.]
A.J. Pinching.
The acquired immune deficiency syndrome: with special reference to tuberculosis.
Tubercle, 68 (1987), pp. 65
[9.]
E. McCray, et al.
Estimating levels and trends among patients of tuberculosis clinics.
Publ Health Rep, 105 (1990), pp. 135
[10.]
World Health Organization.
Press release, (1990),
[11.]
P. Nunn, et al.
Impact of human immunodeficiency virus on transmission and severity of tuberculosis.
Trans R Soc Tropp Hyg, 84 (1990), pp. 9
[12.]
Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET).
MMWR, 38 (1989), pp. 236
[13.]
S.H. Ferebee.
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Adv Tuberc Resp, 17 (1970), pp. 28
[14.]
K.H. Hsu.
Thirty years after isoniazid: its impact on tuberculosis in children and adolescents.
JAMA, 251 (1984), pp. 1.283
[1515]
S.H. Ferebee, et al.
Prevention of experimental tuberculosis with isoniazid.
Am Rev Tuberc Pul Dis, 73 (1956), pp. 1
[16.]
A. Krebs, et al.
Five years of follow-up of the IUAT trial of isoniazid prophylaxis in fibrotic lesions.
Bull Int Unión Against Tuberc, 54 (1979), pp. 65
[17.]
Hong-Kong Chest Service (Tuberculosis Research Center, Madras/British Medical Research Council).
A controlled trial of 2-month, 3-month and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: results at 60 months.
Am Rev Respir Dis, 130 (1984), pp. 23
[18.]
H.F. Lecoeur, et al.
Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
Am Rev Respir Dis, 140 (1989), pp. 1.189
[19.]
P.A. Selwyn, et al.
A prospective study of the risk of tuberculosis in intravenous drug users with human inmunodeficiency virus infection.
N Engl J, 320 (1989), pp. 545
[20.]
H.L. Rieder, et al.
Epidemiology of tuberculosis in the United States.
Epidemiol Review, 11 (1989), pp. 79
[22.]
P.M. Small, et al.
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
N Eng J Med, 324 (1991), pp. 289
[23.]
E. Louie, et al.
Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome.
Chest, 98 (1990), pp. 542
Copyright © 1992. Sociedad Española de Neumología y Cirugía Torácica
